Skip to main content
Back to Bills
FederalDid not become law (session ended)43rd Parliament, 1st Session

Bill C-213 explained in plain English

An Act to enact the Canada Pharmacare Act

Federal Parliament bill summary, status, timeline, sponsor, votes, and official sources.

At a glance

Jurisdiction
Federal Parliament
Legislature / Parliament
Parliament of Canada
Session
43rd Parliament, 1st Session
Bill number
Bill C-213
Full title
An Act to enact the Canada Pharmacare Act
Current status
Did not become law (session ended)
Latest event
At second reading in the House of Commons
Last updated
Feb 27, 2020

Official Parliament of Canada snapshot for 43rd Parliament, 1st Session. MP vote breakdowns appear when the House of Commons publishes a recorded division export for that bill. Senate and House stage details include official debate/sitting links when LEGISinfo publishes them.

Chamber
Parliament of Canada
Current Stage
At second reading in the House of Commons
Latest Activity
Feb 27, 2020
Plain-language explanation
In plain English (our explanation)

Our plain-language take, written for civic education.

Source: By PoliticalData.ca

AI-assisted, reviewed before publishing
Short Version

Bill C-213, if enacted, would create the Canada Pharmacare Act to establish conditions for provincial drug insurance plans to receive federal funding.

What It Means

This bill proposes to create the Canada Pharmacare Act. This Act would establish rules and conditions that provincial drug insurance plans must meet to receive federal cash contributions. It outlines five criteria for these plans: public administration, comprehensiveness, universality, portability, and accessibility. The bill also details a process for the Minister of Health to consult with provinces and potentially refer non-compliance to the Governor in Council, who could then reduce or withhold federal funding. Additionally, it allows for the creation of a federal-provincial drug agency to assess and negotiate drug prices and effectiveness. The Minister would be required to report annually to Parliament on the implementation of the Act.

What This Bill Does
  • Establishes the Canada Pharmacare Act.
  • Defines the policy of the Government of Canada to facilitate access to prescription drugs.
  • Sets out the purpose of the Act as establishing criteria and conditions for federal cash contributions to public drug insurance plans.
  • Specifies that cash contributions may be made to each province for each fiscal year.
  • Outlines five criteria that a province's drug insurance plan must meet to qualify for federal cash contributions: public administration, comprehensiveness, universality, portability, and accessibility.
  • Details the requirements for each of the five criteria.
  • Requires provinces to provide information to the Minister of Health to qualify for cash contributions.
  • Establishes a process for the Minister to refer non-compliance with the criteria or information requirements to the Governor in Council.
  • Allows the Governor in Council to reduce or withhold federal cash contributions to a province if its drug insurance plan does not meet the criteria or conditions.
  • Permits the Minister to enter into arrangements for establishing an independent drug agency.
  • Empowers the Governor in Council to make regulations for the administration of the Act.
  • Requires the Minister to report annually to Parliament on the administration and operation of the Act.
Who Is Affected
  • Provinces
  • The federal government (specifically the Minister of Health)
  • Residents of provinces who are insured persons under provincial drug insurance plans
  • Healthcare practitioners
  • The Governor in Council
  • Parliament
Rights, Duties, Or Obligations
  • Provinces have the right to receive cash contributions if their drug insurance plans meet specified criteria.
  • Provinces have an obligation to administer drug insurance plans according to criteria related to public administration, comprehensiveness, universality, portability, and accessibility.
  • Provinces have an obligation to provide required information to the Minister of Health.
  • The federal government, through the Minister of Health, has the right to assess provincial drug insurance plans against the criteria.
  • The Minister of Health has a duty to consult with provinces regarding potential non-compliance.
  • The Governor in Council has the power to reduce or withhold cash contributions.
  • The Minister is obligated to report annually to Parliament.
  • Federal policy is declared to facilitate access to prescription drugs without financial barriers.
Important Dates
  • Cash contributions may be made for each fiscal year.
  • Drug insurance plans must satisfy the criteria throughout the fiscal year to qualify for contributions.
  • Reductions or withholdings of contributions may be imposed in the fiscal year of the default or the following fiscal year.
  • Orders made by the Governor in Council to reduce or withhold contributions must not come into force earlier than 30 days after notice is sent to the province.
  • The Minister must make an annual report by December 31 following the end of each fiscal year.
  • The Minister must cause the annual report to be laid before Parliament on any of the first 15 days on which that House is sitting after the report is completed.
Financial Or Tax Impacts
  • Provinces may receive cash contributions from the federal government for their drug insurance plans.
  • Cash contributions to provinces may be reduced or withheld if their drug insurance plans do not meet the criteria or conditions set out in the Act.
  • The potential establishment of a drug agency could involve costs related to its operations, assessment, and negotiation functions.
  • The Act focuses on cash contributions, not the imposition of new taxes or direct financial obligations on individuals.
Enforcement Or Penalties
  • If a provincial drug insurance plan is found not to satisfy the criteria, or if a province fails to provide required information, the Minister may refer the matter to the Governor in Council.
  • The Governor in Council may, by order, reduce or withhold cash contributions to a province.
  • Reductions or withholdings may be imposed in the fiscal year of the default or the following fiscal year.
  • Reductions or withholdings must be reimposed for succeeding fiscal years if the default continues.
Uncertainties Or Limits
  • The specific details of "prescribed information" and the "times and manner" for its provision to the Minister are to be determined by regulations (Section 12 and 18(b)).
  • The definition of "insured drug" includes supplies prescribed by regulations, which are not yet detailed in the bill text (Section 2 and 18(a)).
  • The specific amounts of reduction or the exact determination of what constitutes an appropriate reduction for a default are decided by the Governor in Council, based on the gravity of the default (Section 14(1)(a)).
  • The process for the Governor in Council's decision is triggered by the Minister's opinion, but the bill does not specify the exact procedure for the Governor in Council's deliberation beyond the referral.
  • The effectiveness and financial implications of the potential drug agency (Section 17) are not detailed in the bill text.
  • The bill does not specify when it will come into force; this will likely be through a proclamation or a future order.
Laws Or Regulations Affected
Canada Pharmacare Act
creates

This bill enacts a new Act, the Canada Pharmacare Act, which will set out the framework for federal financial contributions to provincial drug insurance plans.

Source: SUMMARY

Canada Pharmacare Act
amends

The bill establishes the conditions and criteria for provincial drug insurance plans to receive cash contributions from the federal government under this new Act.

Source: SUMMARY

Canada Pharmacare Act
amends

The Act defines key terms such as 'cash contribution,' 'drug insurance plan,' 'health care practitioner,' 'insured drug,' 'insured person,' 'Minister,' and 'resident.'

Source: 2

Canada Pharmacare Act
amends

The Act declares the policy of the Government of Canada to facilitate access to prescription drugs without financial barriers.

Source: 3

Canada Pharmacare Act
amends

The Act sets out the purpose of establishing criteria and conditions for cash contributions to public drug insurance plans.

Source: 4

Canada Pharmacare Act
amends

The Act outlines that cash contributions may be made to each province for each fiscal year.

Source: 5

Canada Pharmacare Act
amends

The Act details the five criteria (public administration, comprehensiveness, universality, portability, accessibility) that provincial drug insurance plans must meet to qualify for cash contributions.

Source: 6

Canada Pharmacare Act
amends

The Act specifies how each of the five criteria (sections 7 to 11) is to be met by provincial drug insurance plans.

Source: 7 to 11

Canada Pharmacare Act
amends

The Act requires provincial governments to provide prescribed information to the Minister of Health to qualify for cash contributions.

Source: 12

Canada Pharmacare Act
amends

The Act establishes a process for the Minister of Health to refer to the Governor in Council if a provincial drug insurance plan does not meet the criteria or if a province fails to provide required information.

Source: 13

Canada Pharmacare Act
amends

The Act allows the Governor in Council to reduce or withhold cash contributions to a province if its drug insurance plan does not meet the criteria or conditions.

Source: 14

Canada Pharmacare Act
amends

The Act requires the Minister to reimpose reductions or withholdings for succeeding fiscal years if a province continues to be in default.

Source: 15

Canada Pharmacare Act
amends

The Act permits the Minister, with the approval of the Governor in Council, to enter into arrangements with provincial governments to establish an independent drug agency.

Source: 17

Canada Pharmacare Act
amends

The Act grants the Governor in Council the authority to make regulations for the administration of the Act, including prescribing insured drugs and required information.

Source: 18

Canada Pharmacare Act
amends

The Act requires the Minister to report annually to Parliament on the administration and operation of the Act.

Source: 19

Generated using AI from official bill text. Not legal advice. It is written by PoliticalData.ca for civic education, automatically checked and spot-reviewed before publishing.

Official text

Parliamentary Process

Step 1
First reading
Not reached yet
Not reached

We don't have a plain-language summary for First reading yet. The official source linked below is the full record.

Step 2
Second reading
Not reached yet
Not reached

We don't have a plain-language summary for Second reading yet. The official source linked below is the full record.

Step 3
Third reading
Not reached yet
Not reached

We don't have a plain-language summary for Third reading yet. The official source linked below is the full record.

Step 1
First reading
Feb 24, 2020
Completed

We don't have a plain-language summary for First reading yet. The official source linked below is the full record.

Introduction and first reading, Feb 24, 2020
End of stage activity, Feb 24, 2020
Chamber sittings
Introduction and first reading - Feb 24, 2020

Bill C-213, An Act to enact the Canada Pharmacare Act, was introduced and received first reading in the House of Commons on February 24, 2020.

Step 2
Second reading
Feb 27, 2020
No activity

We don't have a plain-language summary for Second reading yet. The official source linked below is the full record.

Placed in the Order of Precedence, Feb 27, 2020
Step 3
Consideration in committee
Not reached yet
Not reached

We don't have a plain-language summary for Consideration in committee yet. The official source linked below is the full record.

Step 4
Report stage
Not reached yet
Not reached

We don't have a plain-language summary for Report stage yet. The official source linked below is the full record.

Step 5
Third reading
Not reached yet
Not reached

We don't have a plain-language summary for Third reading yet. The official source linked below is the full record.

Debate and sitting links point to official parliamentary sources when LEGISinfo publishes them. Any plain-language discussion summaries should be generated from those official texts and reviewed before public display.

Vote Summary

No published recorded division

This bill is still active. We only show vote counts after the legislature publishes a recorded division.

Sponsor
Peter Julian
Sponsor party or district not listed
Jurisdiction
Federal Parliament

No published representative vote breakdown

This bill is still moving through the process. When a recorded division is published, representative positions can be listed here.

Official sources

Status, sponsor, votes, and timeline on this page are drawn from these official legislative sources and public records. Each summary above is attributed to its own source.

How this data is sourced